Buy Selank 60 mg

€46.03

Selank, 60 mg, is a synthetic tuftsin-related heptapeptide for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific sequence, terminal-form, purity and identity verification.

Category:
Description

Buy Selank, 60 mg, for Advanced Laboratory Research in Europe

Selank is a synthetic seven-residue peptide structurally related to tuftsin and commonly represented as Thr-Lys-Pro-Arg-Pro-Gly-Pro. Research catalogues report either a free C-terminal acid or an amidated form, so the exact terminal chemistry must be confirmed before procurement. The commonly reported free-peptide formula is C₃₃H₅₇N₁₁O₉, with average molecular mass approximately 751.9 Da and CAS Registry Number 129954-34-3. Pharma Research .eu presents this 60 mg format for qualified European laboratory teams.peptide-works+2

Uncompromising Purity and Analytical Characterisation

Selank should be specified using an explicit structural designation. One commonly reported form is:

H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-OH

Other research references describe Selank as:

H-Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH₂

These forms are not identical. The terminal amide changes the molecular composition, molecular mass, charge and chromatographic behaviour. The product page must therefore state whether the supplied 60 mg material is the free-acid peptide, C-terminal amide, acetate salt or another formulation.invivochem+1

For laboratory procurement, the suitable target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Some suppliers use a ≥98% research-grade threshold, while others report ≥99%; the lot-specific chromatogram and identity data should control acceptance.spartalabs+1

A complete CoA should include:

  • RP-HPLC purity percentage, analytical method and chromatogram.

  • LC-MS, ESI-MS or high-resolution MS identity confirmation.

  • Full sequence and terminal-group designation.

  • Free-acid, amidated, acetate or other salt-form information.

  • Molecular formula and molecular-mass assignment for the supplied form.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

For the commonly reported composition C₃₃H₅₇N₁₁O₉, public references give an average molecular mass of approximately 751.87–751.9 g/mol and a monoisotopic mass near 751.4341 Da. If the product is a different terminal or salt form, the formula and mass must be revised accordingly.wikipedia+2

Selank is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is essential because terminal-group variants, deletion sequences, truncated products, oxidation products and residual synthesis materials may substantially affect the behaviour of a small peptide. These impurities can alter retention time, ionisation efficiency, recovery and concentration calculations. A non-characterised product should not be used as a quantitative analytical reference.

Principal Laboratory Applications and Research Methodologies

Selank is suitable for controlled laboratory research involving short-peptide chemistry, analytical characterisation and in vitro biochemical model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. Selank can serve as a defined peptide analyte for retention-time assignment, intact-mass confirmation and impurity profiling. The method should distinguish the free-acid and amidated forms, as well as truncated and oxidation-related species.

Terminal-group and salt-form comparison. Laboratories may compare free-acid Selank with amidated or acetate-associated material to examine effects on charge, retention, ionisation, solubility and sample recovery. Such studies require exact sequence and molecular-mass confirmation for every comparison material.

Peptide stability research. Researchers may investigate the influence of temperature, pH, light, oxidation, moisture and container material. Proline-rich sequences may show adsorption or altered recovery depending on the container and matrix, so stability assessments should include quantitative HPLC or LC-MS.

In vitro biochemical models. A verified Selank lot may be incorporated into controlled cell-free or cellular systems examining peptide-associated signalling or receptor-related responses. Experimental designs should include vehicle controls, blank matrices, concentration confirmation and independent verification that the selected solvent does not affect the assay endpoint.

The 60 mg quantity corresponds to approximately 79.8 µmol using the reported free-peptide mass of 751.9 g/mol. If the material is C-terminally amidated or supplied as a salt, the molar quantity will differ. No working concentration should be displayed without confirming the exact formula, net content, salt form and final preparation volume.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Selank should remain sealed in its lyophilised state until required for a validated laboratory procedure. Research references recommend either refrigerated storage at 2–8°C or frozen storage near −20°C, depending on the supplier and formulation. The lot-specific CoA should take precedence over generic catalogue guidance.peptide-works+2

Recommended controls include:

  • Store unopened lyophilised Selank at −20°C unless the CoA specifies 2–8°C.

  • Consider −80°C for extended archival storage where supported by the stability programme.

  • Keep the container tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8°C only where validated.

  • Use frozen aliquots for longer-term solution storage where supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Record terminal form, solvent, concentration, preparation date, operator and storage history.

Prepared solutions may exhibit adsorption, concentration loss, pH-dependent changes or physical instability. A clear solution should not be assumed to retain its nominal concentration or molecular integrity without chromatographic confirmation.

Reconstitution should be performed using a validated laboratory procedure. Add the selected solvent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless demonstrated to be compatible with the analytical method. If cloudiness or particulates develop, the solution should be investigated before use.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product Selank, 60 mg
Common designation Selank; synthetic tuftsin-related heptapeptide
Common sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro
Terminal form Confirm free acid versus C-terminal amide on the CoA
Residue count 7 amino acids
IUPAC name Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number 129954-34-3
Molecular formula, commonly reported form C₃₃H₅₇N₁₁O₉
Average molecular mass Approximately 751.87–751.9 g/mol
Monoisotopic mass Approximately 751.4341 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target ≥99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, ESI-MS or high-resolution MS
Long-term storage Typically −20°C or 2–8°C according to the CoA; protect from light and moisture

The sequence, formula, mass and CAS number are widely reported, but the terminal-group designation varies between sources. A product page should not describe free-acid Selank and amidated Selank as the same analytical material.peptide-works+3

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position Selank as a documented European laboratory reagent for analytical chemists, biochemists and laboratory managers requiring a defined short peptide. The product file should include a batch-specific CoA, SDS, exact sequence, terminal-group designation, purity result, identity data, salt-form information and storage instructions.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • Free-acid versus amidated Selank.

  • Sequence, stereochemistry and terminal groups.

  • RP-HPLC purity and LC-MS identity testing.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Packaging configuration and container-closure integrity.

  • Solvent and buffer compatibility.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade Selank, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Selank 60 mg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.